Takako Inoue

Pretreatment advanced lung cancer inflammation index (<scp>ALI</scp>) for predicting early progression in nivolumab‐treated patients with advanced non–small cell lung cancer

Takayuki Shiroyama, Hidekazu Suzuki, Motohiro Tamiya et al. · Cancer Medicine · 2017 · 121 citations · Full text

Medicine, Oncology, Inflammation +16

Diagnostic Accuracy of Noninvasive Genotyping of EGFR in Lung Cancer Patients by Deep Sequencing of Plasma Cell-Free DNA

Junji Uchida, Kikuya Kato, Yoji Kukita et al. · Clinical Chemistry · 2015 · 112 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Metastatic site as a predictor of nivolumab efficacy in patients with advanced non-small cell lung cancer: A retrospective multicenter trial

Motohiro Tamiya, Akihiro Tamiya, Takako Inoue et al. · PLoS ONE · 2018 · 109 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Cardiac Adverse Events in EGFR-Mutated Non-Small Cell Lung Cancer Treated With Osimertinib

Kei Kunimasa, Risa Kamada, Toru Oka et al. · JACC CardioOncology · 2020 · 83 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Monitoring of treatment responses and clonal evolution of tumor cells by circulating tumor DNA of heterogeneous mutant EGFR genes in lung cancer

Fumio Imamura, Junji Uchida, Yoji Kukita et al. · Lung Cancer · 2016 · 76 citations

Medicine, Molecular Biology, Oncology +17